Neuro-oncology, a decade of temozolomide and beyond

Roger Stupp; Monika Hegi; Michael Weller

doi:10.1586/era.10.161

Neuro-oncology, a decade of temozolomide and beyond

Roger Stupp^*, Monika Hegi, Michael Weller

^*Corresponding author for this work

Neurological Surgery

Research output: Contribution to journal › Editorial

18 Scopus citations

Original language	English (US)
Pages (from-to)	1675-1677
Number of pages	3
Journal	Expert review of anticancer therapy
Volume	10
Issue number	11
DOIs	https://doi.org/10.1586/era.10.161
State	Published - Nov 1 2010

Keywords

MGMT
bevacizumab
clinical trials
glioma
molecular markers
new agents
temozolomide

ASJC Scopus subject areas

Oncology
Pharmacology (medical)

Access to Document

10.1586/era.10.161

Cite this

Stupp, R., Hegi, M., & Weller, M. (2010). Neuro-oncology, a decade of temozolomide and beyond. Expert review of anticancer therapy, 10(11), 1675-1677. https://doi.org/10.1586/era.10.161

@article{85567c75139a44c0b6b4087a5183bcf4,

title = "Neuro-oncology, a decade of temozolomide and beyond",

keywords = "MGMT, bevacizumab, clinical trials, glioma, molecular markers, new agents, temozolomide",

author = "Roger Stupp and Monika Hegi and Michael Weller",

year = "2010",

month = nov,

day = "1",

doi = "10.1586/era.10.161",

language = "English (US)",

volume = "10",

pages = "1675--1677",

journal = "Expert Review of Anticancer Therapy",

issn = "1473-7140",

publisher = "Expert Reviews Ltd.",

number = "11",

}

TY - JOUR

T1 - Neuro-oncology, a decade of temozolomide and beyond

AU - Stupp, Roger

AU - Hegi, Monika

AU - Weller, Michael

PY - 2010/11/1

Y1 - 2010/11/1

KW - MGMT

KW - bevacizumab

KW - clinical trials

KW - glioma

KW - molecular markers

KW - new agents

KW - temozolomide

UR - http://www.scopus.com/inward/record.url?scp=78649248682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649248682&partnerID=8YFLogxK

U2 - 10.1586/era.10.161

DO - 10.1586/era.10.161

M3 - Editorial

C2 - 21080792

AN - SCOPUS:78649248682

VL - 10

SP - 1675

EP - 1677

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 11

ER -